Salanersen's (BIIB115)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Salanersen's (BIIB115), covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam [Phase 3]